Publications by Shanta Dhar

Accepted | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002

Books/Chapters | Patents | Conferences/Symposiums Abstracts

Citations and h-index(= 38)

Accepted

2023

(86) Kalathil, A. A.; Guin, S.; Ashokan, A.; Basu, U.; Surnar, B.; Delma, K. S.; Lima, L. M.; Kryvenko, O. N.; and Dhar, S. "New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance"
ACS Cent. Sci., 2023, 9, 1297–1312. Link

(85) Zhang, X.; Sarkar, S.; Ashokan, A.; Surnar, B.; Kolishetti, N.; and Dhar, S. "All-in-One pyruvate dehydrogenase kinase inhibitor for tracking, targeting, and enhanced efficacy"
Bioconj. Chem., 2023, 34, 1122–1129. Link

(84) Banik, B.; Ashokan, A.; Choi, J. H.; Surnar, B.; and Dhar, S. "Platin-C containing nanoparticles: A recipe for the delivery of curcumin-cisplatin combination chemotherapeutics to mitochondria"
Dalton Trans., 2023, 52, 3575-3585. Link

2022

(83) Ciciriello, A. J.; Surnar, B.; Medy, G. D.; Su, X.; Dhar, S.; and Dumont C. M. "Biomaterial-targeted precision nanoparticle delivery to the injured spinal cord"
Acta Biomaterialia, 2022, 152, 532-545. Link

(82) Spencer, A. C.; Surnar, B.; Kolishetti, N.; Toborek, M.; and Dhar, S. "Restoring the neuroprotective capacity of glial cells under opioid addictions"
Addiction Neuroscience, 2022, 4, 100027. Link

(81) Hamdan, S.; Surnar, B.; Kafkoutsou, A. L.; Magurno, L.; Deo, S.; Jayaweera, D T.;  Dhar, S.; and Daunert, S. "Transformation of amphiphilic antiviral drugs into new dimensional nanovesicles structures"
ACS Omega, 2022, 7, 21359-21369. Link

(80) Shah, A.; Surnar, B.; Kolishetti, N.; and Dhar, S. "Intersection of inorganic chemistry and nanotechnology for the creation of new cancer therapies"
Acc. Mater. Res, 2022, 3, 283–296. Link

(79) Deo, S.; Dhar, S.; and Daunert, S. "Drug delivery: Challenges and nanotechnology-based solutions"
Mol. Asp. Med., 2022, 83, 101051. Link

(78) Kolishetti, N.; Vashist, A.; Arias, A. Y.; Atluri, S.; Dhar, S.; and Nair, M. "Recent advances, status, and opportunities of magneto-electric nanocarriers for biomedical applications"
Mol. Asp. Med., 2022,83, 101046. Link

(77) Costoya, J.; Surnar, B.; Kalathil, A. A.; Kolishetti, N.; and Dhar, S. "Controlled release nanoplatforms for three most commonly used chemotherapeutics"
Mol. Asp. Med., 2022, 83 101043. Link

2021

(76) Shah, A.; Lopez, I.; Surnar, B.; Sarkar, S.; Duthely, L. M.; Pillai, A.; Salguero, T. T.; and Dhar, S. "Turning the tide for academic women in STEM: A postpandemic vision for supporting female scientists"
ACS Nano, 2021, 15, 18647-18652. Link

(75) Olagunju, M.; Zahran, E.; Zeynaloo, E.; Shukla, D.; Cohn, J. L.; Surnar, B.; Dhar, S.; Bachas, L. G.; Knecht, M. R. "Design of Pd-decorated SrTiO3/BiOBr heterojunction materials for enhanced visible light-based photocatalytic reactivity"
Langmuir, 2021, 37, 11986-11995. Link

(74) Surnar, B.; Shah, S. A.; Park, M.; Kalathil, A. A.; Kamran, M. Z.; Jaime, R. R.; Toborek, M.; Nair, M.; Kolishetti, N.; and Dhar, S. "Brain-accumulating nanoparticles for assisting astrocytes to reduce human immunodeficiency virus and drug abuse-induced neuroinflammation and oxidative stress"
ACS Nano, 2021, 15, 15741-15753. Link

(73) Surnar, B.; Shah, S. A.; Guin, S.; Kolishetti, N.; Fornoni, A.; and Dhar, S. "Blending of designer synthetic polymers to a dual targeted nanoformulation for SARS-CoV-2 associated kidney damage"
Biomacromolecules, 2021, 22, 4244-4250. Link

(72) Olagunju, M.; Zahran, E.; Reed, J. M.; Zeynaloo, E.; Shukla, D.; Cohn, J. L.; Surnar, B.; Dhar, S.; Bachas, L. G.; Knecht, M. R. "Halide effects in BiVO₄/BiOX heterostructures decorated with Pd nanoparticles for photocatalytic degradation of rhodamine B as a model organic pollutant"
ACS Appl. Nano Mater., 2021, 4, 3262-3272. Link

(71) ElMetwally, A. E.;  Zeynaloo, E.; Shukla, D.; Surnar, B.; Dhar, S.; Cohn, J. L.; Knecht, M. R.; Bachas, L. G. "Cu₂O cubes decorated with azine-based covalent organic framework spheres and Pd nanoparticles as tandem photocatalyst for light-driven degradation of chlorinated biphenyls"
ACS Appl. Nano Mater., 2021, 4, 2795-2805. Link

(70) Sarmah, D.; Banerjee, M.; Datta, A.; Kalia, K.; Dhar, S.; Yavagal, D. R.; and Bhattacharya, P. "Nanotechnology in the diagnosis and treatment of stroke"
Drug Discov. Today, 2021, 26, 585-592. Link

2020

(69) Surnar, B.; Kamran, M. Z.; Shah, S. A.; and Dhar, S. "Clinically approved anti-viral drug in an orally administrable nanoparticle for COVID-19"
ACS Pharmacol. Transl. Sci., 2020, 3, 1371-1380 . Link

(68) Kolb, D.; Kolishetti, N.; Surnar, B.; Sarkar, S.; Guin, S.; Shah, S. A.; and Dhar, S. "Metabolic modulation of the tumor microenvironment leads to multiple checkpoint inhibition and immune cell infiltration"
ACS Nano, 2020, 14, 11055-11066. Link

(67) Olagunju, M.; Poole, X.; Blackwelder, P.; Thomas, M. P.; Guiton, B. S.; Shukla, D.; Cohn, J. L.; Surnar, B.; Dhar, S.; Zahran, E.; Bachas, L. G.; Knecht, M. R. "Size-controlled SrTiO3 nanoparticles photodecorated with Pd co-catalysts for photocatalytic organic dye degradation"
ACS Appl. Nano Mater., 2020, 3, 4904-4912. Link

(66) Banik, B.; Surnar, B.; Askins, B.; Banerjee, M.; and Dhar, S. "Dual targeted synthetic nanoparticle for cardiovascular diseases"
ACS Appl. Mater. Interfaces, 2020,  12, 6852-6862. Link

2019

(65) Surnar, B.; Kamran, M. Z.; Shah, S. A.; Basu, U.; Kolishetti, N.; Deo, S.; Jayaweera, D T.; and Daunert, S.; and Dhar, S. "Orally administrable therapeutic synthetic nanoparticle for Zika virus"
ACS Nano, 2019, 13, 11034-11048. Link

(64) Velichkovska, M.; Surnar, B.; Nair, M.; Dhar, S.; and Toborek, M. “Targeted mitochondrial CoQ10 delivery attenuates antiretroviral drug-induced senescence of neural progenitor cells”
Mol. Pharmaceut., 2019, 16, 724-736. Link

2018

(63) Surnar, B.; Basu, U.; Banik, B.; Ahmad, A.; Marples, B.; Kolishetti, N.; and Dhar, S. "Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection"
Proc. Natl. Acad. Sci. USA, 2018, 115, E12333-E12342. Link

(62) Surnar, B.; Kolishetti, N.; Basu, U.; Ahmad, A.; Goka, E.; Marples, B.; Kolb, D.; Lippman, M.; and Dhar, S. "Reduction of cisplatin induced ototoxicity without compromising its antitumor activity"
Biochemistry, 2018, 57, 6500–6513. Link

(61) Pathak, R. K.; Basu, U.; Ahmad, A.; Sarkar, S.; Kumar, A.; Surnar, B.; Ansari, S.; Wilczek, K.; Ivan, M. E.; Marples, B.; Kolishetti, N.; and Dhar, S. "A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation"
Biomaterials, 2018, 187, 117-129. Link

(60) Goodwin, J.; Choi, H.; Hsieh, M-H.; Neugent, M. L.; Ahn, J-M.; Hayenga, H. N.; Singh, P. K.; Shackelford, D. B.; Lee, I-K.; Shulaev, V.; Dhar, S.; Takeda, N.; and Kim, J-W. "Targeting hypoxia-inducible factor-1α/pyruvate dehydrogenase kinase 1 axis by dichloroacetate suppresses bleomycin-induced pulmonary fibrosis"
Am. J. Respir. Cell. Mol. Biol., 2018, 58, 216-231. Link

(59) Banik, B.; Wen, R.; Marrache, S.; Kumar, A.; Kolishetti, N.; Howerth, E.; and Dhar, S. "Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution"
Nanoscale, 2018, 10, 366-377. Link

(58) Banik, B.; and Dhar, S. "Centrifugation free magnetic isolation of functional mitochondria using paramagnetic iron oxide nanoparticles"
Curr. Protoc. Cell Biol., 2018, 76, 25.4.1-25.4.20. Link

2017

(57) Marples, B.; and Dhar, S. "Radiobiology and the renewed potential for nanoparticles"
Int. J. Radiation Oncol. Biol. Phys., 2017, 98, 489-491. Link

(56) Pathak, R. K.; Wen, R.; Kolishetti, N.; and Dhar, S. "A prodrug of two approved drugs, cisplatin and chlorambucil, for chemo war against cancer "
Mol. Cancer Ther, 2017, 16, 625-636. Link

2016

(55) Banik, B.; Askins, B. W.; and Dhar, S. "Mito-magneto: a tool for nanoparticle mediated mitochondria isolation"
Nanoscale, 2016, 8, 19581-19591. Link

(54) Basu, U.; Banik, B.; Wen, R.; Pathak, R. K.;and Dhar, S. "The platin-x series: activation, targeting, and delivery "
Dalton Trans., 2016, 45, 12992-13004. Link

(53) Wen, R.; and Dhar, S. "Turn up the cellular power generator with vitamin E analogue formulation "
Chem. Sci., 2016, 7, 5559-5567.Link

(52) Wen, R.; Umeano, A. C.; Francis, L.; Sharma, N.; Tundup, S.; and Dhar, S. "Mitochondrion: a promising target for nanoparticle-based vaccine"
Vaccines 2016, 4(2), 18. Link

(51) Pathak, R. K. and Dhar, S. "Combined chemo-anti-inflammatory prodrugs and nanoparticles"
Synlett, 2016, 27, 1607-1612.Link

(50) Chaudhary, A.; Bhat, T.; Kumar, S.; Kumar, A.; Kumar, R.; Underwood, W.; Koochekpour, S.; Shourideh, M.; Yadav, N.; Dhar, S.; Chandra, D "Mitochondria dysfunction-mediated apoptosis resistance associates with defective heat shock protein response in african american men with prostate cancer"
Br. J. Cancer, 2016, 114, 1090-1100. Link

(49) Wen, R.; Banik, B.; Pathak, R. K.; Kumar, A.; Kolishetti, N.; and Dhar, S. "Nanotechnology inspired tools for mitochondrial dysfunction related diseases"
Adv. Drug Deliv. Rev., 2016, 99, 52-69. Link

(48) Pathak, R. K. and Dhar, S. "Unique use of alkylation for chemo-redox activity by a Pt(IV) prodrug"
Chem. Eur. J., 2016, 22, 3029-3036. Link

(47) Kalathil, A. A.; Kumar, A.; Banik, B.; Ruiter, T. A.; Pathak, R. K.; and Dhar, S. "New formulation of old aspirin for better delivery"
Chem. Commun., 2016, 52, 140-143. Link

2015

(46) Feldhaeusser, B.; Platt, S. R.; Marrache, S.; Kolishetti, N.; Pathak, R. K.; Montgomery, D. J.; Reno, L. R. Howerth, E.; and Dhar, S. "Evaluation of Nanoparticle Delivered Cisplatin in Beagles"
Nanoscale, 2015, 7, 13822-13830. Link

(45) Pathak, R. K.; and Dhar, S. "A nanoparticle cocktail: Temporal release of predefined drug combinations"
J. Am. Chem. Soc., 2015, 137, 8324-8327. Link

(44) Pathak, R. K.; Kolishetti, N.; and Dhar, S. "Targeted nanoparticles in mitochondrial medicine"
WIREs Nanomed. Nanobiotechnol., 2015, 7, 315-329. Link

(43) Marrache, S.; Tundup, S.; Harn, D. A.; and Dhar, S. "Ex vivo generation of functional immune cells by mitochondria-targeted photosensitization of cancer cells", Weissig V. and Edeas M. Eds. In
Mitochondrial Medicine, Methods in Molecular Biology, Springer, New York, 2015, Vol 1265, 113-22. Link

(42) Marrache, S.; Pathak, R. K.; and Dhar, S. "Formulation and optimization of mitochondria-targeted polymeric nanoparticles", Weissig V. and Edeas M. Eds. In
Mitochondrial Medicine, Methods in Molecular Biology; Springer, New York, 2015, Vol 1265, 103-12. Link

(41) Hung, S. W.; Marrache, S.; Cummings, S.; Bhutia, Y. D.; Mody, H.; Hooks, S. B.; Dhar, S. and Govindarajan, R. " Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: Overcoming transport defects using a nanoparticle approach"
Cancer Lett., 2015, 359, 233-240. Link

(40) Marrache, S.; and Dhar, S. "The energy blocker inside the power house: Mitochondria targeted delivery of 3-bromopyruvate"
Chem. Sci., 2015, 6, 1832-1845. Link

2014

(39) Marrache, S.; Pathak, R. K.; and Dhar, S. "Detouring of cisplatin to access mitochondrial genome for overcoming resistance"
Proc. Natl. Acad. Sci. USA, 2014, 111, 10444-10449. Link

(38) Pathak, R. K.; McNitt, C. D.; Popik, V. V. and Dhar, S. "Copper-free click-chemistry platform to functionalize cisplatin prodrugs"
Chem. Eur. J., 2014, 20, 6861-6865. Link

(37) Pathak, R. K.; Marrache, S.; Harn, D. A. and Dhar, S. "Mito-DCA: A mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate"
ACS Chem. Biol., 2014, 9, 1178-1187. Link

(36) Pathak, R. K.; Marrache, S.; Choi, J. H.; Berding, T. B. and Dhar, S. "The prodrug Platin-A: Simultaneous release of cisplatin and aspirin"
Angew. Chem. Int. Ed., 2014, 53, 1963-1967. Link

2013

(35) Marrache, S.; Tundup, S.; Harn, D. A. and Dhar, S. "Ex vivo programming of dendritic cell by mitochondria-targeted nanoparticles to produce interferon-gamma for cancer immunotherapy"
ACS Nano, 2013, 7, 7392-7402. Link

(34) Hung, S. W.; Mody, H.; Marrache, S.; Bhutia, Y. D.; Davis, F.; Cho, J. H.; Zastre, J.; Dhar, S.; Chu, C. K. and Govindarajan, R. "Pharmacological reversal of histone methylation presensitizes pancreatic cancer cells to nucleoside drugs: In vitro optimization and novel nanoparticle delivery studies"
PLOS ONE, 2013, 8(8), e71196. Link

(33) Marrache, S. Pathak, R. K.; Darley, K. L.; Choi, J. H.; Zaver, D.; Kolishetti, N. and Dhar, S. "Nanocarriers for tracking and treating diseases"
Curr. Med. Chem., 2013, 20, 3500-3514. Link

(32) Marrache, S. and Dhar, S. "Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis"
Proc. Natl. Acad. Sci. USA, 2013, 110, 9445-9450. Link

(31) Marrache, S.; Choi, J. H.; Tundup, S.; Zaver, D.; Harn, D. A. and Dhar, S. "Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer"
Integr. Biol., 2013, 5, 215-223. Link

2012

(30) Marrache, S. and Dhar, S. "Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics"
Proc. Natl. Acad. Sci. USA, 2012, 109, 16288-16293. Link

2011

(29) Dhar, S.; Kolishetti, N.; Lippard, S. J. and Farokhzad, O. C. "Targeted delivery of cisplatin prodrug for safer and more effective prostate cancer therapy in vivo"
Proc. Natl. Acad. Sci. USA, 2011, 108, 1850-1855. Link

(28) Roy, M.; Dhar, S.; Maitya, B. and Chakravarty, A. R. "Dicopper(II) complexes showing DNA hydrolase activity and monomeric adduct formation with bis(4-nitrophenyl)phosphate"
Inorg. Chim. Acta., 2011, 375, 173-180. Link

2010

(27) Kolishetti, N.; Dhar, S.; Valencia, P.; Lin, L.; Karnik. R.; Lippard, S. J.; Langer, R. and Farokhzad, O. C. "Engineering of self-assembled nanoparticle platform for precisely-controlled combination drug therapy"
Proc. Natl. Acad. Sci. USA, 2010, 107, 17939-17944. Link

(26) Lee, T.; Zhang, X.; Dhar, S.; Faas, M. S.; Lippard, S. J. and Jasanoff, A. P. "In vivo imaging with a cell-permeable porphyrin-based MRI contrast agent"
Chem. Biol., 2010, 17, 665-673. Link

2009

(25) Dhar, S.; Daniel, W. L.; Giljohann, D. A.; Mirkin, C. A. and Lippard, S.J. "Polyvalent oligo-modified gold nanoparticles as delivery vehicles for platinum(IV) warhead"
J. Am. Chem. Soc., 2009, 131, 14652-14653. Link

(24) Dhar, S. and Lippard, S. J. "Mitaplatin, A Potent Fusion of Cisplatin and the Orphan Drug Dichloroacetate"
Proc. Natl. Acad. Sci. USA, 2009, 106, 22199-22204. Link

2008

(23) Dhar, S.; Gu, F. X.; Langer, R.; Farokhzad, O. C. and Lippard, S. J. "Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles"
Proc. Natl. Acad. Sci. USA, 2008, 105, 17356-17361. Link

(22) Tennyson, A. G.; Dhar, S. and Lippard, S. J. "Syntheses of {Ni(NO)}₁₀ and {Co(NO)₂}₁₀ complexes supported by thiolate ligands: Insight into the nitric oxide chemistry of iron thiolate complexes in biology"
J. Am. Chem. Soc., 2008, 130, 15087-15098. Link

(21) Dhar, S.; Liu, Z.; Thomale, J.; Dai, H. and Lippard, S. J. "Targeted single walled carbon nanotube mediated Pt(IV) prodrug delivery using folate as homing device"
J. Am. Chem. Soc., 2008, 130, 11467-11476. Link

(20) Roy, S.; Patra, A. K.; Dhar, S. and Chakravarty, A. R. "Photosensitizer in a molecular bowl and its effect on the DNA binding and cleavage activity of 3d-metal scorpionates"
Inorg. Chem., 2008, 47, 5625-5633. Link

2007

(19) Dhar, S.; Kodama, T. and Greenberg, M. M. "Selective detection and quantification of oxidized abasic lesions in DNA"
J. Am. Chem. Soc., 2007, 129, 8702-8703. Link

2006

(18) Dhar, S.; Nethaji, M. and Chakravarty, A. R. "DNA cleavage on photoexposure at the d-d band in ternary copper(II) complexes using red-light laser"
Inorg. Chem., 2006, 45, 11043-11050. Link

2005

(17) Dhar, S.; Nethaji, M. and Chakravarty, A. R. "Steric protection of photosensitizer in a N,N-bis[2-(2-pyridyl)ethyl]-2-phenylethylamine-copper(II) bowl that enhances red light-induced DNA cleavage activity"
Inorg. Chem., 2005, 44, 8876-8883. Link

(16) Dhar, S. and Chakravarty, A. R. "Photosensitizer in a molecular bowl: Steric protection enhancing the photonuclease activity of copper(II) scorpionates"
Inorg. Chem., 2005, 44, 2582-2584. Link

(15) Patra, A. K.; Dhar, S.; Nethaji, M. and Chakravarty, A. R. "Metal-assisted red light-induced DNA cleavage by ternary L-methionine copper(II) complexes of planar heterocyclic bases"
Dalton Trans., 2005, 896-902. Link

(14) Dhar, S.; Nethaji, M. and Chakravarty, A. R. "Synthesis, crystal structure and photo-induced DNA cleavage activity of ternary copper(II) complexes of NSO-donor Schiff bases and NN-donor heterocyclic ligands"
Inorg. Chim. Acta., 2005, 358, 2437-2444. Link

(13) Gupta, T.; Patra, A. K.; Dhar, S.; Nethaji, M. and Chakravarty, A. R. "Effect of copper-sulfur bond on the DNA photocleavage activity of 2-(methylthio) ethylpyridine-2-carbaldimine copper(II) complexes"
J. Chem. Sci., 2005, 117, 123-132. Link

(12) Dhar, S.; Nethaji, M. and Chakravarty, A. R. "Effect of charge transfer bands on the photo-induced DNA cleavage activity of [1-(2-thiazolylazo)-2-naphtholato]copper(II) complexes"
J. Inorg. Biochem., 2005, 99, 805-812. Link

(11) Mukherjee, A.; Dhar, S.; Nethaji, M. and Chakravarty, A. R. "Ternary iron(II) complex with an emissive imidazopyridine arm from Schiff base cyclizations and its oxidative DNA cleavage activity"
Dalton Trans., 2005, 349-353. Link

(10) Dhar, S.; Nethaji, M. and Chakravarty, A. R. "Designing molecules for PDT: red light-induced DNA cleavage on disulfide bond activation in a dicopper(II) complex"
Dalton Trans., 2005, 344-348. Link

2004

(9) Pradhan, R.; Thomas, A. M; Mukherjee, A; Dhar, S.; Nethaji, M. and Chakravarty, A. R. "Synthesis, crystal structute and DNA hydrolysis activity of ternary (N-salicylidene-L-methioninato)copper(II) complexes of heterocyclic bases"
Indian J. Chem., 2004, 43A, 2307-2314. Link

(8) Dhar, S.; Nethaji, M. and Chakravarty, A. R. "Synthetic analogue approach for the functional domains of copper(II)-bleomycins and its DNA cleavage activity"
Dalton Trans., 2004, 4180-4184. Link

(7) Gupta, T.; Dhar, S.; Nethaji, M. and Chakravarty, A. R. "Bis(dipyridophenazine)copper(II) complex as major groove directing synthetic hydrolase"
Dalton Trans., 2004, 1896-1900. Link

(6) Dhar, S.; Reddy, P. A. N. and Chakravarty, A. R. "Intramolecular nucleophilic activation promoting efficient hydrolytic cleavage of DNA by (aqua)bis(dipyrido-quinoxaline)copper(II) complex"
Dalton Trans., 2004, 697-698. Link

2003

(5) Patra, A. K.; Dhar, S.; Nethaji, M. and Chakravarty, A. R. "Visible light-induced nuclease activity of a ternary mono-phenanthroline copper(II) complex containing L-methionine as a photosensitizer"
Chem. Commun., 2003, 1562-1563. Link

(4) Dhar, S.; Senapati, D.; Reddy, P. A. N.; Das, P. K. and Chakravarty, A. R. "Metal-assisted red light-induced efficient DNA cleavage by dipyridoquinoxaline- copper(II) complex"
Chem. Commun., 2003, 2452-2453. Link

(3) Dhar, S. and Chakravarty, A. R. "Efficient visible light-induced nuclease activity of a ternary mono-phenanthroline copper(II) complex containing 2-(methylthio)ethylsalicylaldimine"
Inorg. Chem., 2003, 42, 2483-2485. Link

(2) Dhar, S.; Senapati, D.; Das, P. K.; Chattopadhyay, P.; Nethaji, M. and Chakravarty, A. R. "Ternary copper complexes for photo-cleavage of DNA by red light: direct evidence for sulfur to copper charge transfer and d-d band involvement"
J. Am. Chem. Soc., 2003, 125, 12118-12124. Link

2002

(1) Dhar, S.; Reddy, P. A. N.; Saha, M. K.; Nethaji, M.; Mahadevan, S. and Chakravarty, A. R. "Effect of steric encumbrance of tris(3-phenylpyrazolyl)borate on the structure and properties of ternary copper(II) complexes having N,N-donor heterocyclic bases"
Inorg. Chem., 2002, 41, 3469-3476. Link

Back to Top

 

Book Chapters

(4) Dhar, S.; Daniel, W. L.; Giljohann, D. A.; Mirkin, C. A. and Lippard, S.J. "Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads"  C. A. Mirkin Ed. In
Spherical Nucleic Acids, 2020, Vol 4, Chapter 91, pp 1585-1591. Link

(3) Wen, R.; Umeano, A. C.; and Dhar, S. "Accessing mitochondrial targets using nanocargos", V. Weissig and A. Prokop, Eds. In
Intracellular Delivery III; Springer International Publishing, Switzerland, 2016, pp 229-254.Link

(2) Dhar, S. and Lippard, S. J. "Current status and mechanism of action of platinum-based anticancer drugs", E. Alessio Ed. In
Bioinorganic Medicinal Chemistry; Wiley-VCH, Weinheim, Germany, 2011, pp 79-95. Link

(1) Dhar, S. and Lippard, S. J. "Structural and mechanistic studies of anticancer platinum drugs: Uptake, activation, and the cellular response to DNA binding", A Bonetti et al. Eds. In
Platinum and other heavy metal compounds in cancer chemotherapy; Humana Press, NJ, 2009, pp 135-147. Link

Back to Top

 

Patents

PCT Int. Appl., 2016, WO 2016106328 A1 20160630. Link